{"text": "bristol-myers squibb company $bmy svp joseph c. caldarella sells 9,340 shares URL"}
{"text": "price moves vs expected moves $arry $abbv $mdt $agn $vrx $azn $biib $pfe $teva $bmy $gild $celg\u00a1\u00ad URL"}
{"text": "update: $bmy also releases follow-up data showing a 3-year survival benefit to opdivo vs. docetaxel in nsclc URL"}
{"text": "$bmy bristol-myers squibb option order flow sentiment is 76.6% bullish. URL"}
{"text": "rt AT_USER 5 things for #pharma #marketers to know: fri, sept 8 $pfe $myl #epipen #fda $bmy #immunotherapy #cancer #opioid $mrk URL"}
{"text": "rt AT_USER 5 things for #pharma #marketers to know: fri, sept 8 $pfe $myl #epipen #fda $bmy #immunotherapy #cancer #opioid $mrk URL"}
{"text": "5 things for #pharma #marketers to know: fri, sept 8 $pfe $myl #epipen #fda $bmy #immunotherapy #cancer #opioid\u00a1\u00ad URL"}
{"text": "bristol-myers squibb company $bmy stake decreased by first midwest bank trust division URL"}
{"text": "rt AT_USER $bmy 2 pivotal opdivo trials show 3 year survival benefit in patients with previously treated advanced #nsclc  URL"}
{"text": "s&amp;p100 #stocks performance $gd $amgn $msft $nee $rtn $bmy $celg $cat $fdx $jnj $pcln $mdt $dis $agn $intc  more@ URL"}
{"text": "exelixis recovers from bristol-inspired pitfall in kidney cancer $exel $bmy URL"}
{"text": "optimistic about $bmy #stocks URL"}
{"text": "stockman wealth management inc. sells 4,295 shares of bristol-myers squibb company $bmy URL"}
{"text": "legal &amp; general group plc grows stake in bristol-myers squibb company $bmy URL"}
{"text": "rt AT_USER $ahgif vip-patient electronic medical records and medicant dispensing system URL  $gwph $ibb $jnj $gil\u00a1\u00ad"}
{"text": "rt AT_USER $ahgif multi million $ revenues cannabis biotech with 300% upside potential $ibb $gild $gwph $mrk $nvs $bmy $jnj URL"}
{"text": "rt AT_USER $gwph gw pharma plans uk expansion, alternate health corp $ahgif q2 revenue of $7.2m up 87% from q1 URL"}
{"text": "rt AT_USER $ahgif vip-patient electronic medical records and medicant dispensing system URL  $gwph $ibb $jnj $g\u00a1\u00ad"}
{"text": "rt AT_USER $ahgif multi million $ revenues cannabis biotech with 300% upside potential $ibb $gild $gwph $mrk $nvs $bmy $jnj URL"}
{"text": "rt AT_USER $gwph gw pharma plans uk expansion, alternate health corp $ahgif q2 revenue of $7.2m up 87% from q1 URL"}
{"text": "rt AT_USER $ahgif multi million $ revenues cannabis biotech with 300% upside potential $ibb $gild $gwph $mrk $nvs $bmy $jnj URL"}
{"text": "rt AT_USER $gwph gw pharma plans uk expansion, alternate health corp $ahgif q2 revenue of $7.2m up 87% from q1 URL"}
{"text": "rt AT_USER $ahgif vip-patient electronic medical records and medicant dispensing system URL  $gwph $ibb $jnj\u00a1\u00ad"}
{"text": "rt AT_USER $ahgif multi million $ revenues cannabis biotech with 300% upside potential $ibb $gild $gwph $mrk $nvs $bmy $jnj URL"}
{"text": "rt AT_USER $gwph gw pharma plans uk expansion, alternate health corp $ahgif q2 revenue of $7.2m up 87% from q1 URL"}
{"text": "rt AT_USER $ahgif vip-patient electronic medical records and medicant dispensing system URL  $gwph $ibb $jnj $gil\u00a1\u00ad"}
{"text": "rt AT_USER $ahgif multi million $ revenues cannabis biotech with 300% upside potential $ibb $gild $gwph $mrk $nvs $bmy $jnj URL"}
{"text": "rt AT_USER $ahgif multi million $ revenues cannabis biotech with 300% upside potential $ibb $gild $gwph $mrk $nvs $bmy $jnj URL"}
{"text": "rt AT_USER $ahgif multi million $ revenues cannabis biotech with 300% upside potential $ibb $gild $gwph $mrk $nvs $bmy $jnj URL"}
{"text": "rt AT_USER $gwph gw pharma plans uk expansion, alternate health corp $ahgif q2 revenue of $7.2m up 87% from q1 URL"}
{"text": "rt AT_USER $ahgif vip-patient electronic medical records and medicant dispensing system URL  $gwph $ibb $jnj $g\u00a1\u00ad"}
{"text": "rt AT_USER $ahgif multi million $ revenues cannabis biotech with 300% upside potential $ibb $gild $gwph $mrk $nvs $bmy $jnj URL"}
{"text": "rt AT_USER $gwph gw pharma plans uk expansion, alternate health corp $ahgif q2 revenue of $7.2m up 87% from q1 URL"}
{"text": "rt AT_USER $ahgif vip-patient electronic medical records and medicant dispensing system URL  $gwph $ibb $jnj $g\u00a1\u00ad"}
{"text": "rt AT_USER $ahgif multi million $ revenues cannabis biotech with 300% upside potential $ibb $gild $gwph $mrk $nvs $bmy $jnj URL"}
{"text": "rt AT_USER $gwph gw pharma plans uk expansion, alternate heath corp $ahgif q2 revnue of $7.2m up 87% from q1 URL"}
{"text": "rt AT_USER $ahgif vip-patient electronic medical records and medicant dispensing system URL   $gwph $ibb $jnj $\u00a1\u00ad"}
{"text": "rt AT_USER $ahgif multi million $ revenues cannabis biotech with 300% upside potential $ibb $gild $gwph $mrk $nvs $bmy $jnj URL"}
{"text": "rt AT_USER $ahgif revenues stem mostly from its clinical lab subsidiary, alternate health labs. $aapl $spy $gild $gwph $jnj $ibb $m\u00a1\u00ad"}
{"text": "rt AT_USER $ahgif revenues stem mostly from its clinical lab subsidiary, alternate health labs. $aapl $spy $gild $gwph $jnj $ibb $\u00a1\u00ad"}
{"text": "rt AT_USER $ahgif vip-patient electronic medical records and medicant dispensing system URL  $gwph $ibb $jnj $\u00a1\u00ad"}
{"text": "rt AT_USER $ahgif vip-patient electronic medical records and medicant dispensing system URL   $gwph $ibb $jnj\u00a1\u00ad"}
{"text": "rt AT_USER $ahgif revenues stem mostly from its clinical lab subsidiary, alternate health labs. $aapl $spy $gild $gwph $jnj $ibb $\u00a1\u00ad"}
{"text": "rt AT_USER $ahgif revenues stem mostly from its clinical lab subsidiary, alternate health labs. $aapl $spy $gild $gwph $jnj $ibb $\u00a1\u00ad"}
{"text": "rt AT_USER $ahgif revenues stem mostly from its clinical lab subsidiary, alternate health labs. $aapl $spy $gild $gwph $jnj $ibb $\u00a1\u00ad"}
{"text": "rt AT_USER $ahgif vip-patient electronic medical records and medicant dispensing system URL  $gwph $ibb $jnj $\u00a1\u00ad"}
{"text": "as bristol myers squibb co $bmy share value declined, capital planning advisors has lowered stake by $675,352 ..."}
{"text": "bristol-myers squibb company $bmy downgraded by vetr inc. to hold URL"}
{"text": "rt AT_USER with #exascale expect quantum leap in #ai #ml #robotics #aerospace #auto #pharma $goog $msft $intc $aapl $amd $amzn $f $gm $\u00a1\u00ad"}
{"text": "brokerages set bristol-myers squibb company $bmy target price at $61.61 URL"}
{"text": "brokerages set bristol-myers squibb company $bmy target price at $61.61 URL"}
{"text": "rt AT_USER with #exascale expect quantum leap in #ai #ml #robotics #aerospace #auto #pharma $goog $msft $intc $aapl $amd $amzn $f $gm $\u00a1\u00ad"}
{"text": "legal &amp; general group plc grows stake in bristol-myers squibb company $bmy URL"}
{"text": "stockman wealth management inc. sells 4,295 shares of bristol-myers squibb company $bmy URL"}
{"text": "$ahgif revenues stem mostly from its clinical lab subsidiary, alternate health labs. $aapl $spy $gild $gwph $jnj\u00a1\u00ad URL"}
{"text": "bmy top news - sep 8th, 2017 $bmy URL"}
{"text": "$ahgif vip-patient electronic medical records and medicant dispensing system URL   $gwph $ibb $jnj $gild $vrx $nvs $bmy"}
{"text": "rt AT_USER best commercial slide on pd1/l1 in nsclc $bmy $mrk URL"}
{"text": "rt AT_USER #esmo17 cm067+cm069 pooled analyses $bmy URL"}
{"text": "$ahgif vip-patient electronic medical records and medicant dispensing system URL  $gwph $ibb $jnj $gild $vrx $nvs $bmy"}
{"text": "rt AT_USER best commercial slide on pd1/l1 in nsclc $bmy $mrk URL"}
{"text": "opdivo combo shows early survival benefit in kidney cancer URL $bmy"}
{"text": "opdivo combo shows early survival benefit in kidney cancer URL $bmy"}
{"text": "$ahgif revenues stem mostly from its clinical lab subsidiary, alternate health labs. $aapl $spy $gild $gwph $jnj $ibb $mrk $bmy $nvs $bsx"}
{"text": "s&amp;p100 #stocks performance $gd $amgn $msft $nee $rtn $bmy $celg $cat $fdx $jnj $pcln $mdt $dis $agn $intc  more@ URL"}
{"text": "bristol-myers squibb company $bmy earns hold rating from credit suisse group URL"}
{"text": "vetr users have downgraded bristol-myers sq... to a hold rating (3 stars), giving $bmy a target price of $64.20 URL"}
{"text": "bristol-myers squibb company $bmy given hold rating at credit suisse group URL"}
{"text": "rt AT_USER AT_USER AT_USER great one! making my double in $bmy look bad with that triple. i had sep 59 calls"}
{"text": "bristol-myers squibb company $bmy given hold rating at credit suisse group URL"}
{"text": "best commercial slide on pd1/l1 in nsclc $bmy $mrk URL"}
{"text": "rt AT_USER #esmo17 cm067+cm069 pooled analyses $bmy URL"}
{"text": "AT_USER AT_USER great one! making my double in $bmy look bad with that triple. i had sep 59 calls"}
{"text": "bristol-myers' opdivo study meets early success, stock up URL $bmy $sgen $pfe $mrk"}
{"text": "survival win has $bmy #opdivo-yervoy combo looking better as first-line #kidneycancer treatment #cancer #io #pharma  URL"}
{"text": "bristol-myers squibb company's hold rating reiterated at credit suisse group. URL $bmy #bmy"}
{"text": "2 big reasons exelixis, inc. added $626 million to its market cap in august URL $exel $bmy"}
{"text": "5 things for #pharma #marketers to know: fri, sept 8 $pfe $myl #epipen #fda $bmy #immunotherapy #cancer #opioid\u00a1\u00ad URL"}
{"text": "$regn &amp; $sny bag breakthrough status for pd-1 latecomer #cscc #biotech #skincancer #asco #io $bmy $mrk $rhhby $azn URL"}
{"text": "#esmo17 roundup: $mrk data on #keytruda/chemo combo for #lungcancer takes early spotlight at esmo #biotech $bmy $azn URL"}
{"text": "rt AT_USER missed yesterday's news? here's what to know #pharma $bmy $celg #clinicaltrials #fda $lly $amgn $azn #mhealth $abbv URL"}
{"text": "rt AT_USER #esmo17 cm067+cm069 pooled analyses $bmy URL"}
{"text": "analysts offer insights on healthcare companies: bristol myers (nyse: bmy) and amgen inc (nasdaq: amgn) $bmy URL"}
{"text": "$bmy strong buy ok?"}
{"text": "rt AT_USER #esmo17 cm067+cm069 pooled analyses $bmy URL"}
{"text": "rt AT_USER unusual call buying: $bms 58x average volume, $gpro 6x, $bmy 6x, $abbv 5x, $t 5x, $aig 5x, $cbs 4x, $de 4x"}
{"text": "rt AT_USER $bmy 2 pivotal opdivo trials show 3 year survival benefit in patients with previously treated advanced #nsclc  URL"}
{"text": "rt AT_USER #esmo17 cm067+cm069 pooled analyses $bmy URL"}
{"text": "unusual call buying: $bms 58x average volume, $gpro 6x, $bmy 6x, $abbv 5x, $t 5x, $aig 5x, $cbs 4x, $de 4x"}
{"text": "$bmy been looking hot this week. finally."}
{"text": "rt AT_USER $bac $aapl $t $fb $ge $dis $bmy $cmcsa $tsla $gild $baba $hd $snap $amzn $msft $twtr - today's most active options URL"}
{"text": "AT_USER AT_USER AT_USER they need to take out $bmy but i don't think $500m is going to cover it.  opdivo is a beast!"}
{"text": "$bmy is active on the market, #trading at $62.84 (+4.99%)  check out our #sentiment analysis tool free: URL #investing"}
{"text": "rt AT_USER #esmo17 cm067+cm069 pooled analyses $bmy URL"}
{"text": "AT_USER very good news in pts whom experience a cr, bad news for $bmy dcf models.  luckily (or unluckily)\u00a1\u00ad URL"}
{"text": "rt AT_USER \"in case of cr after 6-mo we propose to d/c therapy with pt consent\" $bmy"}
{"text": "rt AT_USER #esmo17 cm067+cm069 pooled analyses $bmy URL"}
{"text": "in case of cr after 6-mo we propose to d/c therapy with pt consent\" $bmy"}
{"text": "rt AT_USER #esmo17 cm067+cm069 pooled analyses $bmy URL"}
{"text": "rt AT_USER #esmo17 cm067+cm069 pooled analyses $bmy URL"}
